IL6 and myeloid sarcoma: IL6 is considered an important pro-inflammatory cytokine contributing to MS pathology [26,43,44] based on preclinical studies in animal models [45,46] and on clinical observations of an association between higher CSF levels of IL6 and severity of disease [43,44].